GERMS最新文献

筛选
英文 中文
Comparative phenotypic and proteomic analysis of colistin-exposed Pseudomonas aeruginosa. 暴露于粘菌素的铜绿假单胞菌的比较表型和蛋白质组学分析。
IF 1.7
GERMS Pub Date : 2024-09-30 eCollection Date: 2024-09-01 DOI: 10.18683/germs.2024.1436
Nguyen Bao Vy Tran, Thuc Quyen Huynh, Hong Loan Ngo, Ngoc Hoa Binh Nguyen, Thi Hiep Nguyen, Thi Hang Tong, Thi Truc Ly Trinh, Van Dung Nguyen, Le Nhat Minh Pham, Prem Prakash Das, Teck Kwang Lim, Qingsong Lin, Thi Thu Hoai Nguyen
{"title":"Comparative phenotypic and proteomic analysis of colistin-exposed <i>Pseudomonas</i> <i>aeruginosa</i>.","authors":"Nguyen Bao Vy Tran, Thuc Quyen Huynh, Hong Loan Ngo, Ngoc Hoa Binh Nguyen, Thi Hiep Nguyen, Thi Hang Tong, Thi Truc Ly Trinh, Van Dung Nguyen, Le Nhat Minh Pham, Prem Prakash Das, Teck Kwang Lim, Qingsong Lin, Thi Thu Hoai Nguyen","doi":"10.18683/germs.2024.1436","DOIUrl":"https://doi.org/10.18683/germs.2024.1436","url":null,"abstract":"<p><strong>Introduction: </strong>The emergence of colistin resistance threatens the treatment of <i>Pseudomonas aeruginosa</i> infections.</p><p><strong>Methods: </strong>In this study, in vitro development of colistin resistance was investigated using comparative phenotypic and proteomic analysis of <i>P. aeruginosa</i> ATCC 9027, its 14-day colistin sub-MIC exposed strain (Col-E1), and 10-day antibiotic-free cultured Col-E1 strain (Col-E2). Antibiotic susceptibility, morphology, virulence factors, and proteomic changes were assessed using disc-diffusion, agar-based, spectrophotometry, SEM, and iTRAQ-LC-MS/MS methods.</p><p><strong>Results: </strong>Colistin-exposed strains decreased susceptibility to colistin while remaining susceptible to other antibiotics. Col-E1 reduced the cell lengths by 17.67% and the colony size by 36.16% compared to the initial strain. The reduction remained in Col-E2. The pyocyanin production was reduced in Col-E1 (p=0.025, Tukey HSD) and increased again in Col-E2 (p=0.005, Tukey HSD). In contrast, no significant changes in elastase, protease, rhamnolipid, pyoverdine, and biofilm production were observed (p>0.05, Tukey HSD). In Col-E1, the proteome analysis showed 135 differentially expressed proteins (DEPs) of which 94 DEPs (69.23%) maintained their expression change in Col-E2. Among DEPs, 82 were involved in metabolism and protein synthesis. Some DEPs (6/135) played a role in stress response such as GrpE (fold change: 14.93) and Hmp (fold change: 12.08). In particular, membrane proteins like OprD, DdlB, and OprI showed significant colistin response with fold change of -8.47, 6.43 and 6.19, respectively.</p><p><strong>Conclusions: </strong>In summary, colistin response in <i>P. aeruginosa</i> seemed to affect morphology, production of pyocyanin, and proteins of metabolism, protein synthesis, stress response and membrane.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 3","pages":"246-266"},"PeriodicalIF":1.7,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Varicella zoster virus central nervous system infection - a retrospective study from a tertiary center in Greece. 水痘带状疱疹病毒中枢神经系统感染——来自希腊某三级中心的回顾性研究。
IF 1.7
GERMS Pub Date : 2024-09-30 eCollection Date: 2024-09-01 DOI: 10.18683/germs.2024.1437
Konstantinos Alexakis, Petros Ioannou, George Sourvinos, Diamantis P Kofteridis
{"title":"Varicella zoster virus central nervous system infection - a retrospective study from a tertiary center in Greece.","authors":"Konstantinos Alexakis, Petros Ioannou, George Sourvinos, Diamantis P Kofteridis","doi":"10.18683/germs.2024.1437","DOIUrl":"https://doi.org/10.18683/germs.2024.1437","url":null,"abstract":"<p><strong>Introduction: </strong>Central nervous system (CNS) infection due to the varicella zoster virus (VZV) can complicate the primary infection or the reactivation, leading to significant mortality and morbidity. This study aimed to describe the clinical, laboratory, and radiological characteristics of patients with confirmed VZV CNS infection in a tertiary hospital in Greece.</p><p><strong>Methods: </strong>Data about patients hospitalized from January 2018 to September 2023 with CNS infection by VZV, confirmed by a syndromic polymerase chain reaction in the cerebrospinal fluid (CSF), were retrospectively collected and evaluated.</p><p><strong>Results: </strong>In total, 14 patients were recorded. The median age was 49 years, and 35.7% were male. Headache was present in 71.4%, a rash in 57.1%, and fevers, nausea or vomiting, and disorientation in 35.7%. The CSF showed lymphocytic pleocytosis in all patients. Brain magnetic resonance imaging was performed in 53.8%. Empirical antivirals were given in 69.2%, and intravenous acyclovir was given to all patients after identification of VZV in the CSF. Only 7.1% (1 patient) required intensive care unit admission, and 7.1% (1 patient) died. Patients presenting without a rash may be slightly younger, have a slightly lower Charlson comorbidity index, be more likely to present with photophobia or phonophobia, and have lower serum CRP.</p><p><strong>Conclusions: </strong>Patients presenting with VZV CNS infection have lymphocytic pleocytosis in the CSF and usually have a favorable outcome with antiviral treatment. Those presenting without a rash may have a different overall clinical phenotype from those with a rash; however, this must be evaluated in larger studies in the future.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 3","pages":"267-276"},"PeriodicalIF":1.7,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703585/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of risk factors for household-based dengue virus infection in Borobudur Subdistrict, Magelang, Indonesia. 印度尼西亚马格朗婆罗浮屠街道家庭登革热病毒感染危险因素调查。
IF 1.7
GERMS Pub Date : 2024-09-30 eCollection Date: 2024-09-01 DOI: 10.18683/germs.2024.1438
Naufal Arif Ismail, Jamaluddin Haikhah, Evania Tasnim Fauziah, Muhammad Adam Prabasunu, Fadila Husnia Rahma, Siswanto Siswanto, Vita Widyasari
{"title":"Investigation of risk factors for household-based dengue virus infection in Borobudur Subdistrict, Magelang, Indonesia.","authors":"Naufal Arif Ismail, Jamaluddin Haikhah, Evania Tasnim Fauziah, Muhammad Adam Prabasunu, Fadila Husnia Rahma, Siswanto Siswanto, Vita Widyasari","doi":"10.18683/germs.2024.1438","DOIUrl":"https://doi.org/10.18683/germs.2024.1438","url":null,"abstract":"<p><strong>Introduction: </strong>Dengue infection poses a serious threat to global public health, including Indonesia. The rapid spread and significant economic impact are crucial concerns for control efforts. Investigating risk factors of dengue virus infection is necessary to formulate effective strategies, particularly at the household level. This study aims to investigate contributing risk factors to dengue virus transmission in the Borobudur Subdistrict, Magelang, Indonesia, an area with persistently high dengue infection mortality rates.</p><p><strong>Methods: </strong>This study adopted a case-control design and utilized secondary data collected from six villages in the Borobudur Subdistrict. A total of 111 households (37 cases and 74 controls) participated in the study and completed a questionnaire encompassing: 1) Sociodemographic data; 2) Healthy housing components; 3) Sanitation and behavioral components; and 4) Dengue infection prevention practices. Data were analyzed bivariately using statistical software to identify differences in group proportions.</p><p><strong>Results: </strong>The findings of this study indicate that the presence of stagnant water (odds ratio [OR]: 5.02) and mosquito larvae (OR: 4.80) around the house, morning sleep habits (OR: 6.97), and lack of participation in anti-dengue programs (OR: 3.23) are significant risk factors (p<0.05) for dengue infection. However, no significant differences (p>0.05) were found in healthy housing components between the case and control groups.</p><p><strong>Conclusions: </strong>This study has identified contributing risk factors to dengue virus transmission in the Borobudur Subdistrict. These results can serve as a foundation for designing more effective intervention programs for dengue infection and future prevention efforts.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 3","pages":"277-286"},"PeriodicalIF":1.7,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703583/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesizing and assessing influenza vaccine evidence: Strengths and limitations of the recent ECDC report on the effectiveness of new and enhanced influenza vaccines. Communication on: the "European Centre for Disease Prevention and Control. Systematic review update on the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory confirmed influenza in individuals aged 18 years and over. Stockholm: ECDC; 2024". 综合和评估流感疫苗证据:最近ECDC关于新型和增强型流感疫苗有效性报告的优势和局限性。来文:“欧洲疾病预防和控制中心”。关于用于预防18岁及以上人群实验室确诊流感的新型和增强型季节性流感疫苗的功效、有效性和安全性的系统评价最新情况。斯德哥尔摩:ECDC;2024”。
IF 1.7
GERMS Pub Date : 2024-09-30 eCollection Date: 2024-09-01 DOI: 10.18683/germs.2024.1441
George Kassianos, Rok Civljak, Gerrit Adrianus van Essen, Oana Falup Pecurariu, Filipe Froes, Andrey Galev, Kadri Kõivumägi, Zuzana Kristufkova, Ernest Kuchar, Jan Kyncl, Helena C Maltezou, Miloš Marković, Anne Mosnier, Raúl Ortiz de Lejarazu Y Leonardo, Alessandro Rossi, Jörg Schelling
{"title":"Synthesizing and assessing influenza vaccine evidence: Strengths and limitations of the recent ECDC report on the effectiveness of new and enhanced influenza vaccines. Communication on: the \"European Centre for Disease Prevention and Control. Systematic review update on the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory confirmed influenza in individuals aged 18 years and over. Stockholm: ECDC; 2024\".","authors":"George Kassianos, Rok Civljak, Gerrit Adrianus van Essen, Oana Falup Pecurariu, Filipe Froes, Andrey Galev, Kadri Kõivumägi, Zuzana Kristufkova, Ernest Kuchar, Jan Kyncl, Helena C Maltezou, Miloš Marković, Anne Mosnier, Raúl Ortiz de Lejarazu Y Leonardo, Alessandro Rossi, Jörg Schelling","doi":"10.18683/germs.2024.1441","DOIUrl":"https://doi.org/10.18683/germs.2024.1441","url":null,"abstract":"<p><p>High quality research is critical for evidence-based decision making in public health and fundamental to maintain progress and trust in immunization programs in Europe. In 2024 the European Centre for Disease Prevention and Control (ECDC) conducted an update of the 2020 systematic review to capture more recent evidence on of the efficacy, effectiveness of influenza vaccines in individuals aged 18 years and older in the prevention of laboratory-confirmed influenza. While this report was highly anticipated due to the strength of the protocol and processes put in place, during our assessment, we expressed two chief concerns. We are concerned by the grading of the evidence certainty applied and being unable to reproduce some data extracted in the report from the primary sources. While the systematic review benefited of strong methods and processes, the execution of the research protocol warrants revision due to the issues discussed. We encourage the ECDC to work towards an updated review within a reasonable time frame to avoid misinterpretation by decision-making bodies across Europe.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 3","pages":"301-305"},"PeriodicalIF":1.7,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703587/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitamin D and COVID-19: comparative analysis with other respiratory infections and impact of comorbidities. 维生素D与COVID-19:与其他呼吸道感染及合并症影响的比较分析
IF 1.7
GERMS Pub Date : 2024-09-30 eCollection Date: 2024-09-01 DOI: 10.18683/germs.2024.1435
Laura Constantin, Anca Ungurianu, Isabela Ţârcomnicu, Ema Bălulescu, Denisa Margină
{"title":"Vitamin D and COVID-19: comparative analysis with other respiratory infections and impact of comorbidities.","authors":"Laura Constantin, Anca Ungurianu, Isabela Ţârcomnicu, Ema Bălulescu, Denisa Margină","doi":"10.18683/germs.2024.1435","DOIUrl":"https://doi.org/10.18683/germs.2024.1435","url":null,"abstract":"<p><strong>Introduction: </strong>The COVID-19 pandemic has promoted an intensive investigation into the pathophysiological mechanisms of SARS-CoV-2 infection, risk factors, and its impact on disease severity. Vitamin D has generated significant attention for its potential role in viral prevention and immune defense due to its pleiotropic functions, including immunomodulation and antimicrobial effects. This study aimed to assess serum 25(OH)D3 levels in patients with COVID-19 compared to those with other viral respiratory infections and to evaluate associations of vitamin D levels with symptomatology, clinical characteristics, presence of comorbidities and laboratory investigation.</p><p><strong>Methods: </strong>The study included 78 patients admitted to a hospital with COVID-19 (52 patients) or other viral respiratory infections (26 patients). Routine blood biomarkers, markers of inflammation, markers of endothelial dysfunction, serum 25(OH)D3 were analyzed, and patients were classified according to vitamin D levels and presence of comorbidities.</p><p><strong>Results: </strong>Most patients had vitamin D levels <30 ng/mL and there was no significant difference in 25(OH)D3 levels between patients with and without COVID-19 (p=0.768). Aging and comorbidity prevalence were significantly increased in the COVID-19 than in the non-COVID-19 group (p<0.001; p=0.049). A significant positive correlation was determined between endocan level and serum ferritin concentration in patients with COVID-19 and vitamin D deficiency. A borderline significantly elevated NLR was observed in patients with COVID-19 who were also vitamin D deficient, compared with the similar non-COVID-19 subgroup (p=0.05). In patients with COVID-19 and insufficient vitamin D, levels of 25(OH)D negatively correlated with endocan. Interestingly, COVID-19 patients with diabetes exhibited significantly lower 25(OH)D3 levels compared to non-diabetic patients (p=0.003), along with higher ferritin levels, suggesting a potential association between vitamin D deficiency and diabetes in COVID-19.</p><p><strong>Conclusions: </strong>These findings contribute to the understanding of the complex interplay between vitamin D status, comorbidities, and COVID-19 outcomes, emphasizing the need for further research to elucidate their underlying mechanisms and clinical implications.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 3","pages":"232-245"},"PeriodicalIF":1.7,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703589/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vivo systemic vancomycin determination from polymethyl methacrylate and morselized bone allograft used in two stage septic knee revision arthroplasty. 聚甲基丙烯酸甲酯和异体骨块在两期化脓性膝关节置换术中的体内系统万古霉素测定。
IF 1.7
GERMS Pub Date : 2024-09-30 eCollection Date: 2024-09-01 DOI: 10.18683/germs.2024.1440
Andrei Bunea, Dan Lăptoiu, Isabela Târcomnicu, Dan Oţelea, Gheorghe Popescu, Rodica Marinescu
{"title":"In vivo systemic vancomycin determination from polymethyl methacrylate and morselized bone allograft used in two stage septic knee revision arthroplasty.","authors":"Andrei Bunea, Dan Lăptoiu, Isabela Târcomnicu, Dan Oţelea, Gheorghe Popescu, Rodica Marinescu","doi":"10.18683/germs.2024.1440","DOIUrl":"https://doi.org/10.18683/germs.2024.1440","url":null,"abstract":"<p><strong>Introduction: </strong>This paper examines the use of local antibiotic therapy in one-stage septic revision surgery for late periprosthetic joint infections (PJIs). This case study suggests that morselized bone allografts impregnated with antibiotics in powder form are a preferable alternative to polymethyl methacrylate (PMMA) because they can generate higher local antibiotic concentrations. Current research also recommends using vancomycin and aminoglycosides as the preferred choice of antibiotics, as they may have low diffusion in tissues when administered intravenously, but are effective when administered locally. The article emphasizes the importance of achieving high local antibiotic concentrations to eradicate bacterial biofilms and provides guidelines for the preparation of bone allografts.</p><p><strong>Case report: </strong>The paper assesses the case study of a 68-year-old male patient who underwent two-stage total revision surgery for a late septic failure of the endoprosthesis (approximatively one year after implantation). The first stage involved removing the implant, debridement, lavage, and setting a fixed spacer manually made from polymethyl methacrylate impregnated with 4 g of vancomycin. The second stage of revision surgery utilized a morselized bone allograft impregnated with 4 g of vancomycin as a means of local antibiotic therapy and bone defect coverage. Systemic levels of vancomycin were measured at 4, 8, 12 and 24 hours respectively after surgery. During this period, no systemic vancomycin was administered. After the second stage was carried out and the testing was carried out, systemic vancomycin therapy was initiated and the plasma levels of the drug were assessed and subsequently therapeutic doses were adjusted.</p><p><strong>Conclusions: </strong>Vancomycin loaded bone allograft achieved higher systemic concentrations that its polymethyl methacrylate counterpart, when being manually loaded with the same amount of antibiotic. Nonetheless, the levels were well below nephrotoxic levels, indicating that this may be a valuable tool for local means of antibiotic therapy in selected patients that could not endure such a systemic therapeutic regiment. For septic revisions, antibiotic loaded bone allograft holds a valuable place in the surgical arsenal of local antimicrobial treatment, by far exceeding that of the polymethyl methacrylate.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 3","pages":"294-300"},"PeriodicalIF":1.7,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703586/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The first case of alveolar echinococcosis from southern Croatia: progressive course of the disease in an immunocompromised patient. 来自克罗地亚南部的第一例肺泡包虫病:免疫功能低下患者的病程进展。
IF 1.7
GERMS Pub Date : 2024-09-30 eCollection Date: 2024-09-01 DOI: 10.18683/germs.2024.1439
Ivan Mihanovic, Relja Beck, Marin Petric, Natasa Males Raskovic, Ana Dunatov Huljev, Dijana Perkovic, Mirela Pavicic Ivelja
{"title":"The first case of alveolar echinococcosis from southern Croatia: progressive course of the disease in an immunocompromised patient.","authors":"Ivan Mihanovic, Relja Beck, Marin Petric, Natasa Males Raskovic, Ana Dunatov Huljev, Dijana Perkovic, Mirela Pavicic Ivelja","doi":"10.18683/germs.2024.1439","DOIUrl":"https://doi.org/10.18683/germs.2024.1439","url":null,"abstract":"<p><strong>Introduction: </strong>Alveolar echinococcosis is one of the most pathogenic zoonoses caused by the larval forms of <i>Echinococcus multilocularis</i>. It is endemic in central Europe, but from 2001 to 2018, eight European countries reported their first cases of alveolar echinococcosis. These numbers testify to unprecedented spread of the infection.</p><p><strong>Case report: </strong>We report the first case of alveolar echinococcosis from southern Croatia that was incidentally found in an immunocompromised 70-year-old male patient. He was admitted to the hospital due to macrohematuria and renal insufficiency. Diagnostic assessment of kidney impairment revealed a large liver infiltration whose radiographic appearance was suspicious of a cancer. Nevertheless, histopathological and molecular analysis of the liver biopsy confirmed alveolar echinococcosis. The lesion was irresectable due to expansion along the major liver vessels. Therefore, conservative treatment with albendazole was started and the existing immunosuppressive therapy was modulated. The control imaging following 11 months of albendazole treatment showed regression of the lesions.</p><p><strong>Conclusions: </strong>It is not clear whether this case was imported or autochthonous, but it is evident that the incidence of alveolar echinococcosis is rising in Europe. Due to its rareness and malignant nature of the disease, it is often misdiagnosed or diagnosed late when radical surgical treatment is impossible to perform. Clinicians should be aware of this emerging parasitic disease, especially in immunocompromised patients, because every delay in reaching the diagnosis seriously hampers therapeutic efficacy. Better therapeutic options and standardized guidelines on the modulation of immunosuppressive therapy in these patients are highly needed.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 3","pages":"287-293"},"PeriodicalIF":1.7,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703584/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aggregatibacter actinomycetemcomitans endocarditis in an adult patient with patent ductus arteriosus. 一名患有动脉导管未闭的成年患者的放线菌聚集性心内膜炎。
IF 1.7
GERMS Pub Date : 2024-06-30 eCollection Date: 2024-06-01 DOI: 10.18683/germs.2024.1433
Alina Maria Borcan, Mihaela Cristina Olariu, Elena Liliana Costea, Georgiana Radu, Mădălina Simoiu
{"title":"<i>Aggregatibacter actinomycetemcomitans</i> endocarditis in an adult patient with patent ductus arteriosus.","authors":"Alina Maria Borcan, Mihaela Cristina Olariu, Elena Liliana Costea, Georgiana Radu, Mădălina Simoiu","doi":"10.18683/germs.2024.1433","DOIUrl":"10.18683/germs.2024.1433","url":null,"abstract":"<p><strong>Introduction: </strong><i>Aggregatibacter</i> (<i>Actinobacillus</i>) <i>actinomycetemcomitans</i> is a commensal bacterial pathogen in the human oral cavity. It can, however, represent the source of local or systemic infections with serious evolution, in particular infective endocarditis. We present a particular case of an adult male patient with infective endocarditis with <i>A. actinomycetemcomitans</i> and patent ductus arteriosus (PDA).</p><p><strong>Case report: </strong>A 37-year-old patient, chronic ethanol user, is hospitalized for altered general condition, persistent cough, left chest pain, headache and dizziness, symptoms evolving for about 3 weeks. The clinical examination revealed crackling pulmonary rales present basally bilaterally, as well as numerous cavities and dental abscesses. Chest radiography showed mixed left hiliobasal pneumonia. Chest CT depicted pulmonary abscess and two filling defects in the pulmonary artery trunk, possible thrombotic/vegetative images/mediastinal thrombotic/adenopathic images. Broad spectrum antibiotic treatment was initiated. Transthoracic ultrasonography visualized persistence of ductus arteriosus and an echodense formation attached to the lateral wall of the pulmonary artery trunk. Following positive blood cultures for <i>Aggregatibacter actinomycetemcomitans</i>, the diagnosis of infective endocarditis was established and antibiotic treatment was de-escalated to ceftriaxone according to the antibiogram. The clinical course under treatment was slowly favorable, the patient was discharged on request on day 44 with continued treatment at home.</p><p><strong>Conclusions: </strong>Infective endocarditis caused by <i>Aggregatibacter actinomycetemcomitans</i> should be considered in patients with altered general condition and congenital cardiovascular defects. In the present case, the patient presented two risk factors, namely poor dental hygiene and PDA.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 2","pages":"210-215"},"PeriodicalIF":1.7,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527487/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The spectrum of esophagitis in patients living with HIV - a scoping review. 艾滋病病毒感染者食管炎的范围--范围界定综述。
IF 1.7
GERMS Pub Date : 2024-06-30 eCollection Date: 2024-06-01 DOI: 10.18683/germs.2024.1430
Mihaela Cristina Olariu, Mihai Hristu Olariu, Adela Mihaela Iancu, Oana Săndulescu, Anca Streinu-Cercel, Ecaterina Constanţa Barbu, Gülşen Özkaya Şahin, Alina Maria Borcan, Miruna Maria Cruceru, Mădălina Simoiu
{"title":"The spectrum of esophagitis in patients living with HIV - a scoping review.","authors":"Mihaela Cristina Olariu, Mihai Hristu Olariu, Adela Mihaela Iancu, Oana Săndulescu, Anca Streinu-Cercel, Ecaterina Constanţa Barbu, Gülşen Özkaya Şahin, Alina Maria Borcan, Miruna Maria Cruceru, Mădălina Simoiu","doi":"10.18683/germs.2024.1430","DOIUrl":"10.18683/germs.2024.1430","url":null,"abstract":"<p><p>Esophageal lesions are common findings in disorders of the digestive tract in patients living with HIV, the most typical symptoms being odynophagia and/or dysphagia. This article provides a narrative review of the spectrum of esophagitis in patients living with HIV, focusing on fungal, viral, bacterial and non-infectious etiologies, as well as co-infections with viral hepatitis viruses. The article provides a comprehensive approach to the strategy of diagnosis and the role of upper digestive endoscopy and histopathological examination in the evaluation of esophageal pathology in patients living with HIV.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 2","pages":"188-196"},"PeriodicalIF":1.7,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527493/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142569208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Linoleic acid acts as a potential anti-virulence agent in Klebsiella pneumoniae. 亚油酸是肺炎克雷伯氏菌的一种潜在抗病毒剂。
IF 1.7
GERMS Pub Date : 2024-06-30 eCollection Date: 2024-06-01 DOI: 10.18683/germs.2024.1426
Jayalaxmi Wangkheimayum, Tuhina Banerjee, Somorita Baishya, Swati Sharma, Manabendra Dutta Choudhury, Monjur Ahmed Laskar, Amitabha Bhattacharjee
{"title":"Linoleic acid acts as a potential anti-virulence agent in <i>Klebsiella pneumoniae</i>.","authors":"Jayalaxmi Wangkheimayum, Tuhina Banerjee, Somorita Baishya, Swati Sharma, Manabendra Dutta Choudhury, Monjur Ahmed Laskar, Amitabha Bhattacharjee","doi":"10.18683/germs.2024.1426","DOIUrl":"10.18683/germs.2024.1426","url":null,"abstract":"<p><strong>Introduction: </strong>The rise in antimicrobial resistance among bacterial pathogens is a global concern, and anti-virulence therapy may be an alternative strategy to address the issue. Multidrug resistant (MDR) hypervirulent <i>Klebsiella pneumoniae</i> (HvKp) is known to be associated with healthcare associated infections. These are often challenging to treat and here anti-virulence therapy may be a treatment option. The study of anti-virulence compounds against HvKp by in-silico prediction, in-vitro experiments and in-vivo assay enables to determine which anti-virulence compounds are suitable for an alternative approach MDR HvKp.</p><p><strong>Methods: </strong>Modeling of the proteins, ligand binding and molecular docking were performed targeting different hypervirulence genes viz., <i>rmpA</i>, <i>rmpA2</i> and, <i>iroC</i> by in-silico analysis using different bioinformatics tool and software. Minimum inhibitory concentration (MIC) was determined for six anti-virulence compounds; curcumin, eugenol, reserpine, linoleic acid, ε-anethole, and α-thujone by standard protocol. Quantitative real-time PCR was performed selecting two isolates harboring <i>rmpA, rmpA2</i> and <i>iroC</i> genes. <i>Galleria mellonella</i> larva killing assay was used for in-vivo experiment.</p><p><strong>Results: </strong>In-silico analysis observed that linoleic acid could be the best fit in comparison with the other compounds. None of the anti-virulence compounds showed any inhibitory activity and upon transcriptional expression analysis of the hypervirulence genes; <i>rmpA</i> was marginally increased for both the isolates when linoleic acid exposure was given.</p><p><strong>Conclusions: </strong>In-vivo study revealed that linoleic acid and reserpine showed anti-virulence activity.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 2","pages":"136-148"},"PeriodicalIF":1.7,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信